🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Katherine M. Eichinger

University of Pittsburgh

ORCID: 0000-0002-0968-8513

Also affiliated with NRG Oncology

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection”.

Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection

Frontiers in Immunology(2020)10.3389/fimmu.2020.01673

N/A

0DataRank · unranked

65 citations

Jessica L. Kosanovich, Sonal V. Gidwani, Aaron Zomback, Madeline A. Lipp, Timothy N. Perkins +6 more

Formulation of the prefusion RSV F protein with a Th1/Th2-balanced adjuvant provides complete protection without Th2-skewed immunity in RSV-experienced young mice

Vaccine(2020)10.1016/j.vaccine.2020.08.023

N/A

0DataRank · unranked

19 citations

Katherine M. Eichinger, Madeline A. Lipp, Mark A. Yondola, Timothy N. Perkins, Kerry M. Empey +1 more

Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity

Vaccine(2020)10.1016/j.vaccine.2020.10.065

N/A

0DataRank · unranked

13 citations

Jessica L. Kosanovich, Madeline A. Lipp, Timothy N. Perkins, Nikolai Petrovsky, Christopher Marshall +3 more

Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation

Frontiers in Immunology(2022)10.3389/fimmu.2022.1025341

N/A

0DataRank · unranked

16 citations

Jessica L. Kosanovich, Timothy N. Perkins, Tim D. Oury, Nikolai Petrovsky, Christopher Marshall +3 more

Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy

Cancer Letters(2023)10.1016/j.canlet.2023.216396

N/A

0DataRank · unranked

60 citations

Katherine M. Eichinger, Anju Zhang, Song Li, Zhangyi Luo

Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB/c mice born to PreF-vaccinated dams

Frontiers in Immunology(2023)10.3389/fimmu.2023.1206026

N/A

0DataRank · unranked

10 citations

Katherine M. Eichinger, Madeline A. Lipp, Sonal V. Gidwani, Devarshi Brahmbhatt, Mark A. Yondola +3 more

Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus

Frontiers in Immunology(2024)10.3389/fimmu.2024.1374818

N/A

0DataRank · unranked

0 citations

Katherine M. Eichinger, Madeline A. Lipp, Sonal V. Gidwani, Devarshi Brahmbhatt, Mark A. Yondola +4 more

Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity

Frontiers in Pharmacology(2025)10.3389/fphar.2024.1397995

N/A

0DataRank · unranked

0 citations

Yuyin Wang, Keito Hoshitsuki, Katherine M. Eichinger, Sanjay Rathod, Yin Zhu +7 more